| Financial Year |
March 31 2023 |
| Monetary Funds |
5,461,697,208.59 |
| Held-for-trading Financial Assets |
4,900,000.00 |
| Notes Receivable |
367,327,538.14 |
| Accounts Receivable |
33,331,470,842.64 |
| Advances to Suppliers |
2,581,320,988.90 |
| Other Receivables |
1,331,638,771.54 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
1,697,658.80 |
| Inventories |
8,220,329,741.18 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
46,700,000.00 |
| Other Current Assets |
288,253,153.31 |
| Total Current Assets |
52,326,853,159.19 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
268,024,924.91 |
| Long-term Equity Investment |
3,044,521,832.99 |
| Investment Properties |
169,473,490.97 |
| Fixed Assetes |
2,044,308,647.48 |
| Under-construction Projects |
162,635,306.89 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
255,476,810.75 |
| R&D expenses |
48,051,231.24 |
| Goodwill |
1,508,689,570.40 |
| Long-Term Deferred and Prepaid Expenses |
96,722,052.92 |
| Deferred Income Tax Assets |
236,895,068.59 |
| Other Non-Current Assets |
226,210,470.22 |
| Sub-Total of Non-Current Assets |
8,468,850,350.53 |
| Total Assets |
60,795,703,509.72 |
| Short-Term Loans |
15,105,286,336.39 |
| Trading Financial liabilities |
9,617,562.64 |
| Notes Payable |
2,851,172,088.35 |
| Accounts Payable |
12,709,861,628.60 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
112,701,221.75 |
| Taxes Payable |
337,247,329.30 |
| Interest Payable |
-- |
| Dividend Payable |
62,468,315.18 |
| Other payables |
6,031,368,523.46 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,839,190,220.48 |
| Other Current Liabilities |
2,052,325,526.33 |
| Sub-Total of Current Liabilities |
43,999,557,945.41 |
| Long-term Loans |
1,315,544,967.98 |
| Bonds Payable |
1,599,107,955.69 |
| Long-Term Accounts Payable |
25,560,661.98 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
39,482,281.79 |
| Other Non-Current Liabilities |
319,996,631.46 |
| Sub-Total of Non-Current Liabilities |
3,670,380,479.54 |
| Total Liabilities |
47,669,938,424.95 |
| Paid-In Capital(Or Share Stock) |
1,743,367,337.00 |
| Capital Surplus |
2,436,584,663.54 |
| Surplus Reserve |
152,093,697.37 |
| LESS:Treasury Stock |
41,904,089.16 |
| Undistributed Profits |
6,573,621,797.05 |
| Minority Stockholder's Interest |
2,307,757,095.50 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
10,818,007,989.27 |
| Owner's Equity（Stockholder's Equity） |
13,125,765,084.77 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
60,795,703,509.72 |
